Table 3 The study group’s clinical data regarding vital data, the need for mechanical ventilation, site of care, disease severity classification, HRCT chest radiological affection, standard of care treatment, outcome, and radiological evidence of thrombosis
Vital data | No. = 33 | |
|---|---|---|
Respiratory rate | Mean ± SD | 21.12 ± 5.76 |
Range | 16–38 | |
SpO2 (%) | Mean ± SD | 91.58 ± 10.73 |
Range | 60–99 | |
Need for mechanical ventilation [n (%)] | No | 30 (90.9%) |
Yes | 3 (9.1%) | |
Site of care: Ward/ ICU [ n (%)] | ward | 28 (84.8%) |
ICU | 5 (15.2%) | |
Disease severity [n (%)] | Mild | 14 (42.4%) |
Moderate to severe | 14 (42.4%) | |
Critical | 5 (15.2%) | |
HRCT chest findings [n (%)] | < 50% | 28 (84.8%) |
> 50% | 5 (15.2%) | |
Outcome [n (%)] | ||
Cured/discharged | 30 | (90.9%) |
Continued hospitalization | 1 | (3.03%) |
Death | 2 | (6.06%) |
Duration of hospital admission | Median (IQR) | 15 (12–30) |
Range | 6–120 | |
Radiological evidence of thrombosis | No | 30 (90.9%) |
PE | 2 (6.1%) | |
DVT | 1 (3.0%) | |